Detection of BCR-ABL transcripts in chronic myeloid leukaemia by nested PCR

Leukemia Research

Volumn 23, Issue 2, 1999, Pages 185-190

  Otazú, Ivone B ^a   Zalcberg, Ilana ^a   Tabak, Daniel G ^a   Seuánez, Héctor N ^a,b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

BCR ABL; Chronic myeloid leukaemia; RT PCR

Indexed keywords

BCR ABL PROTEIN;

ARTICLE; BONE MARROW TRANSPLANTATION; CANCER REGRESSION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; PHILADELPHIA 1 CHROMOSOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

BONE MARROW TRANSPLANTATION; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0032907001     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00144-1     Document Type: Article

References (17)

1. Heisterkamp N., Groffen J. Molecular insight into the Philadelphia translocation. Haemat Phatol. 5:1991;1.
2. Ben Neriah Y., Daley G.Q., Mes-Messon A.M., Witte O.N., Baltimore D. The chronic myeloid leukemia specific p210 protein is the product of the BCR-ABL hybrid gene. Science. 223:1984;212.
3. Kawasaki E.S., Clark S.S., Coyne N.Y., Smith S.D., Champlin R., Witte O.N., McCormick F.P. Diagnosis of chronic myeloid and acute Lymphoblastic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA. 86:1988;5698.
4. Hochhaus A., Reiter A., Skladny H., Melo J.V., Sick C., Berger U., Guo J.Q., Arlinghaus R.B., Hehlmann R., Goldman J.M., Cross N.C.P. A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia negative chronic myelogenous leukemia. Blood. 88:1996;2236.
5. Hughes T.P., Morgan G.J., Martiat P., Goldman J.M. Detection of residual leukaemia after bone marrow transplantation for chronic myeloid leukaemia: role of polymerase chain reaction in predicting relapse. Blood. 77:1991;874.
6. Roth M.S., Antin J.H., Ash R., Valeri T.H., Goltlieb M., Silver S.M., Ginsburg D. Prognostic significance of Philadelphia chromosome positive cells detected for polymerase chain reaction after allogeneic bone marrow transplant for chronic myeloid leukemia. Blood. 79:1992;276.
7. Dveksler G.S., Basile A.A., Dieffenbach C.W. Analysis of gene expression: use of oligonucleotide primers for glyceraldehyde-3-phosphate dehydrogenase. PCR Methods Appl. 1:1992;283.
8. Sagayadan G.E., Wiernik P.H., Sun N., Ahearn G., Thomspon D., Hallam S.J., Hu X.-P., Dutcher J.P., Gallarder R.E. Effect of retinoic acid and interferon alpha on granulocyte macrophage colony forming cell in chronic myeloid leukemia. Leuk Res. 18:1994;741.
9. Lozzio C.B., Lozzio B.B. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood. 45:1975;321.
10. Miyamura K., Tahara T., Tanimoto M., Morishita Y., Kawashima K., Morishima Y., Saito H., Tsuzuki S., Takeyama K., Kodera Y., Matsuyama K., Hirabayashi M., Yamada H., Naito K., Imai K., Sakamaki H., Asai O., Mizutani S. Long persistent bcr-abl positive transcript detected for polymerase chain reaction after bone marrow transplant for chronic myelogenous leukemia without clinical relapse: a study of 64 patients. Blood. 81:1993;1089.
11. Negrin R.S., Blume K.G. The use of polymerase chain reaction for the detection of minimal residual malignant disease. Blood. 78:1991;255.
12. Radich J.P., Gehly G., Gooley T., Bryant E., Clift R.A., Collins S., Edmans S., Kirk J., Lee A., Kessler P., Schoch G., Buckner C.D., Sullivan K.M., Appelbaum F.R., Thomas E.D. Polymerase chain-reaction detection of the bcr-abl fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood. 85:1995;2632.
13. Morgan G.J., Janssen J.W.G., Guo A.-P., Wiedemann L.M., Hughes T., Gow J., Goldman J.M., Bartram C.R. Polymerase chain reaction for detection of residual leukaemia. Lancet. 29:1989;928.
14. Lin F., Cross N.C.P. Molecular methods for monitoring malignant disease after bone marrow transplantation. Curr Opin Hematol. 2:1995;460.
15. Van Rhee F., Lin F., Cross N.C.P., Reid C.D.I., Lachani A.K.V., Szydlo R.M., Goldman J.M. Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia. Bone Marrow Transplant. 14:1994;609.
16. Cross N.C.P., Lin F., Chase A., Bungey J., Hughes T.P., Goldman J.M. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia after bone marrow transplantation. Blood. 82:1993;1929.
17. Futaki M., Matsuoka H., Miyake K., Dan K., Nomura T. Relationship of the type of BCR-ABL hybrid mRNA to clinical course and transforming activity in Philadelphia-positive chronic myelogenous leukemia. Leuk Res. 16:1992;1071.